ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $230,868 | +13.2% | 5,692 | -3.1% | 0.13% | +10.5% |
| Q2 2022 | $204,000 | -24.4% | 5,872 | 0.0% | 0.11% | -7.3% |
| Q1 2022 | $270,000 | -30.6% | 5,872 | 0.0% | 0.12% | -19.1% |
| Q4 2021 | $389,000 | -10.8% | 5,872 | -15.9% | 0.15% | -15.6% |
| Q3 2021 | $436,000 | -25.1% | 6,984 | -0.6% | 0.18% | -27.4% |
| Q2 2021 | $582,000 | +17.3% | 7,024 | -4.7% | 0.25% | +17.0% |
| Q1 2021 | $496,000 | -11.9% | 7,373 | 0.0% | 0.21% | -20.0% |
| Q4 2020 | $563,000 | +77.6% | 7,373 | 0.0% | 0.26% | +43.2% |
| Q3 2020 | $317,000 | +0.6% | 7,373 | +1.0% | 0.18% | -3.6% |
| Q2 2020 | $315,000 | +50.0% | 7,303 | -2.4% | 0.19% | +11.6% |
| Q1 2020 | $210,000 | – | 7,482 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |